CN102526103B - 一种多种微量元素注射液药物组合物及其制备方法 - Google Patents
一种多种微量元素注射液药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN102526103B CN102526103B CN2010105757293A CN201010575729A CN102526103B CN 102526103 B CN102526103 B CN 102526103B CN 2010105757293 A CN2010105757293 A CN 2010105757293A CN 201010575729 A CN201010575729 A CN 201010575729A CN 102526103 B CN102526103 B CN 102526103B
- Authority
- CN
- China
- Prior art keywords
- hydrochloric acid
- injection
- chloride
- add
- glycine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002347 injection Methods 0.000 title claims abstract description 20
- 239000007924 injection Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 9
- 239000011573 trace mineral Substances 0.000 title abstract description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 46
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 36
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000004471 Glycine Substances 0.000 claims abstract description 18
- 229960003080 taurine Drugs 0.000 claims abstract description 17
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 12
- 239000000600 sorbitol Substances 0.000 claims abstract description 12
- 239000000243 solution Substances 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000008215 water for injection Substances 0.000 claims description 10
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 6
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 239000003610 charcoal Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 abstract description 35
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract description 22
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 abstract description 15
- 229910021380 Manganese Chloride Inorganic materials 0.000 abstract description 11
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 abstract description 11
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 abstract description 11
- 239000011565 manganese chloride Substances 0.000 abstract description 11
- 235000002867 manganese chloride Nutrition 0.000 abstract description 11
- 239000011684 sodium molybdate Substances 0.000 abstract description 11
- 235000015393 sodium molybdate Nutrition 0.000 abstract description 11
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 abstract description 11
- 239000011592 zinc chloride Substances 0.000 abstract description 11
- 235000005074 zinc chloride Nutrition 0.000 abstract description 11
- 229940099607 manganese chloride Drugs 0.000 abstract description 10
- 239000011781 sodium selenite Substances 0.000 abstract description 10
- 235000015921 sodium selenite Nutrition 0.000 abstract description 10
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 abstract description 9
- 229960001471 sodium selenite Drugs 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 6
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 abstract description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract description 5
- 229910021578 Iron(III) chloride Inorganic materials 0.000 abstract description 5
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 4
- 238000006479 redox reaction Methods 0.000 abstract description 4
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 abstract 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 abstract 2
- 229910021555 Chromium Chloride Inorganic materials 0.000 abstract 1
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 abstract 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 abstract 1
- 229910004619 Na2MoO4 Inorganic materials 0.000 abstract 1
- 229910003424 Na2SeO3 Inorganic materials 0.000 abstract 1
- 239000011636 chromium(III) chloride Substances 0.000 abstract 1
- 235000007831 chromium(III) chloride Nutrition 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 description 15
- 229940090044 injection Drugs 0.000 description 12
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 9
- 229910052804 chromium Inorganic materials 0.000 description 9
- 239000011651 chromium Substances 0.000 description 9
- 239000011734 sodium Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 6
- 239000011775 sodium fluoride Substances 0.000 description 5
- 235000013024 sodium fluoride Nutrition 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 4
- 238000007792 addition Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- -1 Amino Acid Compound Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229940093181 glucose injection Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-N selenous acid Chemical compound O[Se](O)=O MCAHWIHFGHIESP-UHFFFAOYSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
样品编号 | 1 | 2 | 3 | 4 |
甘氨酸 | / | 3mg | / | 3mg |
牛磺酸 | / | / | 3mg | 3mg |
试验现象 | 少量沉淀、溶液变为 | 溶液变为浅黄绿 | 溶液变为浅黄色 | 溶液几乎无 |
黄色 | 色 | 色、澄明液体 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105757293A CN102526103B (zh) | 2010-12-07 | 2010-12-07 | 一种多种微量元素注射液药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105757293A CN102526103B (zh) | 2010-12-07 | 2010-12-07 | 一种多种微量元素注射液药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526103A CN102526103A (zh) | 2012-07-04 |
CN102526103B true CN102526103B (zh) | 2013-11-13 |
Family
ID=46334925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105757293A Active CN102526103B (zh) | 2010-12-07 | 2010-12-07 | 一种多种微量元素注射液药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526103B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103340895B (zh) * | 2013-06-27 | 2015-02-18 | 江西博意特科技有限公司 | 一种含多种微量元素的组合物,其制剂及制备方法 |
CN103479667B (zh) * | 2013-08-23 | 2016-05-11 | 辽宁海思科制药有限公司 | 一种多种微量元素注射液(ⅱ)药物组合物及其制备方法 |
CN107854486A (zh) * | 2016-09-22 | 2018-03-30 | 刘力 | 供注射用的多种微量元素的药物组合物及其用途 |
CN106309488A (zh) * | 2016-09-28 | 2017-01-11 | 北京百奥药业有限责任公司 | 一种小儿多种微量元素注射液 |
CN108042564A (zh) * | 2017-12-15 | 2018-05-18 | 合肥中龙神力动物药业有限公司 | 一种亚硒酸钠维生素c注射液及其制造方法 |
CN108498541A (zh) * | 2018-06-05 | 2018-09-07 | 百正药业股份有限公司 | 一种多种微量元素注射液的制备方法 |
CN113023752A (zh) * | 2021-03-11 | 2021-06-25 | 合肥市未来药物开发有限公司 | 碘化钾及其制备方法和应用 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001026642A2 (en) * | 1999-10-08 | 2001-04-19 | Joyce Corinne Bechthold | Methods and compositions for treating neurobehavioral disorders |
CN1517085A (zh) * | 2003-01-15 | 2004-08-04 | 华瑞制药有限公司 | 多种微量元素注射液与其制备方法及其应用 |
CN1634186A (zh) * | 2003-12-31 | 2005-07-06 | 昆明紫健生物技术有限公司 | 复方丹参氨基酸输液及生产方法 |
CN1700909A (zh) * | 2002-09-17 | 2005-11-23 | 张金俊 | 通过选择性诱导晶状体上皮细胞分离和/或死亡来预防后囊浑浊化的治疗溶液及方法 |
CN1720822A (zh) * | 2004-07-14 | 2006-01-18 | 大连水产学院 | 水产品下脚料中牛磺酸的提取及牛磺酸螯合物的制备 |
CN1830455A (zh) * | 2005-03-08 | 2006-09-13 | 巴里莫尔制药(通化)有限公司 | 一种多种微量元素注射液的制备方法 |
US20070059246A1 (en) * | 2000-04-21 | 2007-03-15 | Bracco Imaging S.P.A. | Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
US20070220806A1 (en) * | 2006-03-24 | 2007-09-27 | Ewart Harry S | Compositions comprising Porphyra and methods of making and using thereof |
CN101522220A (zh) * | 2006-10-19 | 2009-09-02 | 雀巢产品技术援助有限公司 | 用于维持的长期肠内喂养 |
WO2010017405A1 (en) * | 2008-08-06 | 2010-02-11 | Adam Heller | Methods and compositions for the treatment of pain |
EP2184062A1 (en) * | 2005-06-22 | 2010-05-12 | Ajinomoto Co., Inc. | Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators |
-
2010
- 2010-12-07 CN CN2010105757293A patent/CN102526103B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001026642A2 (en) * | 1999-10-08 | 2001-04-19 | Joyce Corinne Bechthold | Methods and compositions for treating neurobehavioral disorders |
US20070059246A1 (en) * | 2000-04-21 | 2007-03-15 | Bracco Imaging S.P.A. | Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
CN1700909A (zh) * | 2002-09-17 | 2005-11-23 | 张金俊 | 通过选择性诱导晶状体上皮细胞分离和/或死亡来预防后囊浑浊化的治疗溶液及方法 |
CN1517085A (zh) * | 2003-01-15 | 2004-08-04 | 华瑞制药有限公司 | 多种微量元素注射液与其制备方法及其应用 |
CN1634186A (zh) * | 2003-12-31 | 2005-07-06 | 昆明紫健生物技术有限公司 | 复方丹参氨基酸输液及生产方法 |
CN1720822A (zh) * | 2004-07-14 | 2006-01-18 | 大连水产学院 | 水产品下脚料中牛磺酸的提取及牛磺酸螯合物的制备 |
CN1830455A (zh) * | 2005-03-08 | 2006-09-13 | 巴里莫尔制药(通化)有限公司 | 一种多种微量元素注射液的制备方法 |
EP2184062A1 (en) * | 2005-06-22 | 2010-05-12 | Ajinomoto Co., Inc. | Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators |
US20070220806A1 (en) * | 2006-03-24 | 2007-09-27 | Ewart Harry S | Compositions comprising Porphyra and methods of making and using thereof |
CN101522220A (zh) * | 2006-10-19 | 2009-09-02 | 雀巢产品技术援助有限公司 | 用于维持的长期肠内喂养 |
WO2010017405A1 (en) * | 2008-08-06 | 2010-02-11 | Adam Heller | Methods and compositions for the treatment of pain |
Also Published As
Publication number | Publication date |
---|---|
CN102526103A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102526103B (zh) | 一种多种微量元素注射液药物组合物及其制备方法 | |
CN101732246A (zh) | 莫西沙星水溶液型注射剂 | |
CN106822175A (zh) | 一种碳酸氢钠林格注射液及其制备方法 | |
CN104971074A (zh) | 多种微量元素组合物及其制备方法 | |
CN103405473A (zh) | 混合糖电解质注射液及其制备方法 | |
Frankel | Supplementation of trace elements in parenteral nutrition: rationale and recommendations | |
CN103385889B (zh) | 混合糖电解质注射液及其制备方法 | |
CN104523582A (zh) | 一种稳定的硫酸特步他林注射液及制备工艺 | |
CN102309515A (zh) | 药物组合物在制备治疗失眠的药物中的用途 | |
CN1517085A (zh) | 多种微量元素注射液与其制备方法及其应用 | |
CN103479667B (zh) | 一种多种微量元素注射液(ⅱ)药物组合物及其制备方法 | |
CN104856946A (zh) | 一种高安全性的地塞米松磷酸钠注射液及其制备工艺 | |
CN111643521A (zh) | 一种含10种微量元素的注射液及制备工艺 | |
CN105560281A (zh) | 一种混合糖电解质注射液及其制备方法 | |
CN108079035A (zh) | 一种降糖消炎营养液及其制备方法 | |
CN101972257B (zh) | 一种含有莫西沙星的药物组合物 | |
CN103463094B (zh) | 一种头孢匹胺钠和小儿复方氨基酸注射液(19aa-i)的药物组合物 | |
CN105520955A (zh) | 一种羧基麦芽糖铁药用组合物及其制备方法 | |
CN107854485A (zh) | 供注射用的多种微量元素的药物组合物及其用途 | |
JP5623682B2 (ja) | 微量元素製剤 | |
EP2085091B1 (en) | Use of hydrochloric acid in manufacture of medicament for treating diabetes | |
WO2024146515A1 (zh) | 一种微量元素组合物、其制备方法和用途 | |
CN1054512C (zh) | 生理性多盐液 | |
CN107854486A (zh) | 供注射用的多种微量元素的药物组合物及其用途 | |
JP5922496B2 (ja) | 微量元素製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 17 No. 856099, Tibet autonomous region, city Zedang town Sanxiang Road Patentee after: Haisike Pharmaceutical Group Limited by Share Ltd Patentee after: Liaoning Haisco Pharmaceutical Co., Ltd. Patentee after: Sichuan Haisco Pharmaceutical Co.,Ltd. Address before: The 856000 Tibet autonomous region in southern area of Zedang town Xiang Qu Road No. 8 Patentee before: Tibet Haisco Pharmaceutical Group Co., Ltd. Patentee before: Liaoning Haisco Pharmaceutical Co., Ltd. Patentee before: Sichuan Haisco Pharmaceutical Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120704 Assignee: Sichuan Meida Kangjiale Pharmaceutical Co., Ltd. Assignor: Haisike Pharmaceutical Group Limited by Share Ltd|Liaoning Haisco Pharmaceutical Co., Ltd.|Sichuan Haisco Pharmaceutical Co.,Ltd. Contract record no.: 2016510000033 Denomination of invention: Multi-trace element injection and preparation method thereof Granted publication date: 20131113 License type: Common License Record date: 20161212 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170906 Address after: 17 No. 856099, Tibet autonomous region, city Zedang town Sanxiang Road Patentee after: Haisike Pharmaceutical Group Limited by Share Ltd Address before: 17 No. 856099, Tibet autonomous region, city Zedang town Sanxiang Road Co-patentee before: Liaoning Haisco Pharmaceutical Co., Ltd. Patentee before: Haisike Pharmaceutical Group Limited by Share Ltd Co-patentee before: Sichuan Haisco Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20190424 Contract record no.: 2016510000033 Assignor after: Haisike Pharmaceutical Group Limited by Share Ltd Assignor before: Haisi Pharmaceutical Group Co., Ltd. Assignor before: Liaoning Haisi Pharmaceutical Co., Ltd. Assignor before: Sichuan Hai Cisco Pharmaceutical Co., Ltd. |
|
EM01 | Change of recordation of patent licensing contract |